Pleasanton

PleasantonCA.city — Tri-Valley neighborhood news with hometown heart.

Back to Local Business

Veeva appoints Dan Rizzo to lead global sales as Schwenger departs

Veeva Systems has named Dan Rizzo as executive vice president of sales, consulting, and services, effective as Thomas D. Schwenger prepares to leave the company in October 2026.

Tobias Teague

August 24, 20262 min read

Corporate leadership transition - illustration, Jake Team LLC

Veeva Systems has appointed Dan Rizzo to serve as executive vice president of sales, consulting, and services. The new role grants Rizzo oversight of the company's global commercial organization. This leadership change occurs as Thomas D. Schwenger, who has held the title of president and chief customer officer, prepares to exit the firm in October 2026.

According to a company announcement, Schwenger is leaving the Pleasanton, California-based cloud software provider to assume the role of chief executive officer at a partner organization. Rizzo will now direct the teams responsible for driving the adoption of Veeva’s product suite within the life sciences sector. The transition aligns with the company’s strategy to integrate its business consulting division more closely with its software platforms.

The leadership shift arrives following a recent commitment from Eli Lilly and Company to deploy Veeva Vault CRM globally. Analysts view this agreement as a sign that major pharmaceutical firms are consolidating commercial workflows on Veeva’s platform. This development is considered a potential driver for growth in subscription and services revenue.

Wall Street attention is currently focused on Veeva’s upcoming fiscal second-quarter 2027 results, which are scheduled for discussion around August 26.

Investors are expected to seek management commentary on sales pipeline quality, customer retention, and suite adoption rates. These metrics are particularly relevant given new global deployments. The combined role Rizzo now holds is tied to capturing larger portions of enterprise transformation budgets at major pharmaceutical clients. Execution in this area is viewed as critical for the company's strategic goals.

Long-term financial projections indicate Veeva aims for revenue of approximately $4.7 billion and earnings of about $1.4 billion by fiscal 2029. This implies annual revenue growth of roughly 12.7% from current levels. Some analysts offer more conservative estimates, projecting revenue near $4.5 billion and earnings of $1.3 billion by the same period.

Other observers note that AI agents in safety and clinical workflows could influence these forecasts.

The departure of a long-serving commercial leader highlights ongoing monitoring of customer concentration risks. Relationships with top-tier pharmaceutical companies are central to Veeva’s CRM and AI rollout. Key metrics for upcoming quarters will include consulting attachment rates on new CRM wins and retention figures across major accounts.

Veeva Systems Inc. employs about 945 people in Pleasanton, according to local government records.

Source: finance.biggo.com.

Sources

https://finance.biggo.com/news/85e3822f-677c-48e9-a532-b5a97a391ba9

Share

Tobias Teague

Tobias Teague reports on local business, new openings, and economic development in Pleasanton.

Related Stories

More in Pleasanton